Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Walkling WD"'
Autor:
F. A. Chrzanowski, J. E. Mills, C. Y. Ko, V. Paragamian, Walkling Wd, J. N. Plampin, R. S. Egan
Publikováno v:
Drug Development and Industrial Pharmacy. 10:241-258
Fenoctimine sulfate was demonstrated to exist in two distinct crystalline forms, i.e., form A (low melting, 0.5 mole water of hydration), and form B (high melting, anhydrous). These forms can exist separately, in crystalline mixtures with each other,
Publikováno v:
Journal of pharmaceutical sciences [J Pharm Sci] 1981 Jul; Vol. 70 (7), pp. 778-80.
Publikováno v:
Journal of parenteral science and technology : a publication of the Parenteral Drug Association [J Parenter Sci Technol] 1982 Sep-Oct; Vol. 36 (5), pp. 190-2.
Publikováno v:
Journal of parenteral science and technology : a publication of the Parenteral Drug Association [J Parenter Sci Technol] 1985 Jan-Feb; Vol. 39 (1), pp. 48-51.
Publikováno v:
Journal of pharmaceutical sciences [J Pharm Sci] 1978 Jul; Vol. 67 (7), pp. 948-50.
Publikováno v:
Journal of pharmaceutical sciences [J Pharm Sci] 1978 Jul; Vol. 67 (7), pp. 945-8.
Autor:
Walkling WD
Publikováno v:
Journal of pharmaceutical sciences [J Pharm Sci] 1977 Nov; Vol. 66 (11), pp. IV.
Autor:
Shangraw RF, Walkling WD
Publikováno v:
Journal of pharmaceutical sciences [J Pharm Sci] 1971 Apr; Vol. 60 (4), pp. 600-2.
Publikováno v:
Journal of pharmaceutical sciences [J Pharm Sci] 1971 Feb; Vol. 60 (2), pp. 333.
Autor:
Walkling WD, Shangraw RF
Publikováno v:
Journal of pharmaceutical sciences [J Pharm Sci] 1968 Nov; Vol. 57 (11), pp. 1927-33.